TABLE 1—
Fentanyl-Involveda Fatal Overdoses (n = 1433) | Nonfentanyl Opioid and Polydrugb Fatal Overdoses (n = 1838) | |
Individual-level covariates | ||
Age, y, mean ±SD | 43.1 ±12.5 | 44.2 ±12.6 |
Race/ethnicity, no. (%) | ||
Non-Latino/a Black | 619 (43.2) | 666 (36.2) |
Non-Latino/a White | 616 (43.0) | 966 (52.6) |
Latino/a | 185 (12.9) | 170 (9.2) |
Other | 13 (0.9) | 36 (2.0) |
Gender, no. (%) | ||
Male | 1114 (77.7) | 1343 (73.1) |
Female | 319 (22.3) | 495 (26.9) |
Neighborhood-level covariates | ||
Household income in $10 000s, median ±SD | 4.79 ±2.76 | 5.08 ±2.82 |
Neighborhood deprivation score | ||
Mean ±SD | −0.04 ±1.84 | −0.45 ±1.81 |
Low (range = −5.00–0.00), no. (%) | 715 (49.9) | 1123 (61.1) |
Moderate (range = 0.01–1.00), no. (%) | 252 (17.6) | 266 (14.5) |
High (range = 1.01–5.00), no. (%) | 466 (32.5) | 449 (24.4) |
Index of Concentration at the Extremes, range = −1 to +1, mean ±SD | −0.11 ±0.74 | 0.07 ±0.73 |
Population density per square mile in 1000s, mean ±SD | 16.4 ±23.0 | 15.3 ±13.1 |
Substances used, identified in medical examiner toxicity screen as primary cause of death, were fentanyl and fentanyl metabolites, carfentanil, 4-ANPP, and U-47700, alone or in combination with drugs listed in footnote b.
Substances used, identified in medical examiner toxicity screen as primary cause of death, were opioids (heroin, codeine, methadone, morphine, hydrocodone, tramadol, oxycodone, oxymorphone, buprenorphine, mitragynine, opioid, opiate) and nonopioids (cocaine, amphetamine, methamphetamine, lysergic acid diethylamide [LSD], 3-fluorophenmetrazine [3-FPM], methylenedioxyamphetamine [MDA], methylenedioxymethamphetamine [MDMA], 7-aminoclonazepam, clonazepam [Klonopin], delorazepam, diazepam [Valium], diclazepam, etizolam, lorazepam [Ativan], midazolam [Versed], nordiazepam, and temazepam [Restoril]).